Luis
Montuenga Badía
Catedrático de Universidad
University of Liverpool
Liverpool, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Liverpool (10)
2023
-
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program
Annals of Epidemiology, Vol. 77, pp. 1-12
2019
-
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 343-357
2013
-
A prognostic DNA methylation signature for stage I non-small-cell lung cancer
Journal of Clinical Oncology, Vol. 31, Núm. 32, pp. 4140-4147
2012
-
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung
Journal of Clinical Oncology, Vol. 30, Núm. 10, pp. 1129-1136
-
Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: The EUELC cohort
European Respiratory Journal, Vol. 40, Núm. 1, pp. 177-184
-
Progressive lung cancer determined by expression profiling and transcriptional regulation
International Journal of Oncology, Vol. 41, Núm. 1, pp. 242-252
-
Smoking history and lung carcinoma: KRAS mutation is an early hit in lung adenocarcinoma development
Lung Cancer, Vol. 75, Núm. 2, pp. 156-160
2010
-
Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: The European Early Lung Cancer Project
International Journal of Oncology, Vol. 37, Núm. 2, pp. 455-461
2009
-
EUELC project: A multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration
European Respiratory Journal, Vol. 34, Núm. 6, pp. 1477-1486